Publications by authors named "Lars Reisaeter"

Claim this Profile
T
Transition to targeted transperineal prostate biopsies does not impact progression to curative treatment for patients initially entered into active surveillance.
Alfred Honore, Christian Arvei Moen, Lars Anders Rokne Reisæter, Karsten Gravdal, Patrick Juliebø-Jones

Urologia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zinner syndrome: Clinical insights from Western Norway.
Emanuel Bjurulf, Lars A R Reisæter, Hemamaalini Rajkumar, Adeel Asghar Chaudhury, Alfred Honoré

Urologia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concordance with final pathology when transitioning from standard transrectal to cognitive targeted transperineal prostate biopsy.
Alfred Honoré, Karsten Gravdal, Patrick Juliebø-Jones, Lars Anders Rokne Reisæter, Christian Beisland

BJUI Compass· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to M. Kamrava and F. Montorsi et al.
Christian Ekanger, Svein Inge Helle, Rune Kvåle, Lars Reisæter, Karsten Gravdal

J Clin Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up.
Christian Ekanger, Svein Inge Helle, Lars Reisæter, Liv Bolstad Hysing, Rune Kvåle

J Clin Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A preoperative magnetic resonance imaging can aid in staging and treatment choice for upper tract urothelial carcinoma.
Bjarte Almås, Lars Anders Rokne Reisæter, Carl Erik Markhus, Karin Margrethe Hjelle, Astrid Børretzen

BJUI Compass· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transitioning from transrectal to transperineal prostate biopsy using a freehand cognitive approach.
Alfred Honoré, Christian Arvei Moen, Patrick Juliebø-Jones, Lars Anders Rokne Reisaeter, Karsten Gravdal

BJU Int· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer.
Astrid Børretzen, Lars A R Reisæter, Anders Ringheim, Karsten Gravdal, Svein A Haukaas

Sci Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer.
Liv Cecilie Vestrheim Thomsen, Alfred Honoré, Lars Anders Rokne Reisæter, Bjarte Almås, Astrid Børretzen

Cancer Immunol Immunother· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of prebiopsy MRI on prostate cancer staging: Results from the Norwegian Prostate Cancer Registry.
Erik Skaaheim Haug, Tor Åge Myklebust, Patrick Juliebø-Jones, Lars Anders Rokne Reisæter, Kirsti Aas

BJUI Compass· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing PSMA-PET/CT with intravenous contrast: Improved tracer clearance in the prostate bed.
Andreas Julius Tulipan, Angela Jaramillo Guzman, Torjan Magne Haslerud, Kjartan Foldnes, Ole Heine Kvernenes

Nuklearmedizin· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "The levels of IL-6 and soluble IL-33R are increased in the renal vein during surgery for clear cell renal cell carcinoma" [Cytokine 144 (2021) 155586].
Gigja Gudbrandsdottir, Helene H Aarstad, Karin M Hjelle, Kristina Førde, Lars Reisæter

Cytokine· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The levels of IL-6 and soluble IL-33R are increased in the renal vein during surgery for clear cell renal cell carcinoma.
Gigja Gudbrandsdottir, Helene H Aarstad, Karin M Hjelle, Kristina Førde, Lars Reisæter

Cytokine· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative predictors of pathological tumour stage and prognosis may be used when selecting candidates for intensified treatment in upper tract urothelial carcinoma.
Bjarte Almås, Stein Øverby, Ole J Halvorsen, Lars A R Reisæter, Birgitte Carlsen

Scand J Urol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic resonance radiomics for prediction of extraprostatic extension in non-favorable intermediate- and high-risk prostate cancer patients.
Are Losnegård, Lars A R Reisæter, Ole J Halvorsen, Jakub Jurek, Jörg Assmus

Acta Radiol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour architecture, grade and location remain predictors of non-organ-confined upper tract urothelial carcinoma at time of radical nephroureterectomy: results from a multicenter Norwegian external validation study.
Bjarte Almås, Stein Øverby, Ole J Halvorsen, Lars A R Reisæter, Jørg Assmus

World J Urol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Extraprostatic Extension with Multiparametric MRI of the Prostate: Mehralivand Extraprostatic Extension Grade or Extraprostatic Extension Likert Scale?
Lars A R Reisæter, Ole J Halvorsen, Christian Beisland, Alfred Honoré, Karsten Gravdal

Radiol Imaging Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten-Year Results From a Phase II Study on Image Guided, Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in High-Risk Prostate Cancer.
Christian Ekanger, Svein Inge Helle, Daniel Heinrich, Dag Clement Johannessen, Ása Karlsdóttir

Adv Radiat Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Norwegian Practice Patterns for Surgical Treatment of Kidney Cancer Tumors ≤7cm: Adherence to Changes in Guidelines May Improve Overall Survival.
Karin M Hjelle, Tom B Johannesen, Leif Bostad, Lars A R Reisæter, Christian Beisland

Eur Urol Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimising preoperative risk stratification tools for prostate cancer using mpMRI.
Lars A R Reisæter, Jurgen J Fütterer, Are Losnegård, Yngve Nygård, Jan Monssen

Eur Radiol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life use of diagnostic biopsies before treatment of kidney cancer: results from a Norwegian population-based study.
Christian Beisland, Tom B Johannesen, Lars Anders R Reisæter, Karin M Hjelle

Scand J Urol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensity-based volumetric registration of magnetic resonance images and whole-mount sections of the prostate.
Are Losnegård, Lars Reisæter, Ole J Halvorsen, Christian Beisland, Aurea Castilho

Comput Med Imaging Graph· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F18-FDG-PET for recurrent differentiated thyroid cancer: a systematic meta-analysis.
Torjan Haslerud, Katrin Brauckhoff, Lars Reisæter, Regina Küfner Lein, Achim Heinecke

Acta Radiol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use.
Christian Beisland, Gigja Guðbrandsdottir, Lars A R Reisæter, Leif Bostad, Karin M Hjelle

World J Urol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary external validation of the Leibovich model for prediction of progression after radical surgery for clear cell renal cell carcinoma.
Christian Beisland, Gigja Gudbrandsdottir, Lars A R Reisæter, Leif Bostad, Tore Wentzel-Larsen

Scand J Urol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis